OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in understanding the role of angiotensin-regulated proteins in kidney diseases
Ana B. Sanz, Adrián M. Ramos, María José Soler, et al.
Expert Review of Proteomics (2018) Vol. 16, Iss. 1, pp. 77-92
Closed Access | Times Cited: 24
Ana B. Sanz, Adrián M. Ramos, María José Soler, et al.
Expert Review of Proteomics (2018) Vol. 16, Iss. 1, pp. 77-92
Closed Access | Times Cited: 24
Showing 24 citing articles:
Targeting the progression of chronic kidney disease
Marta Ruíz-Ortega, Sandra Rayego‐Mateos, Santiago Lamas, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 5, pp. 269-288
Closed Access | Times Cited: 703
Marta Ruíz-Ortega, Sandra Rayego‐Mateos, Santiago Lamas, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 5, pp. 269-288
Closed Access | Times Cited: 703
Renin-angiotensin system and inflammation update
Elena Cantero‐Navarro, Beatriz Fernández‐Fernández, Adrián M. Ramos, et al.
Molecular and Cellular Endocrinology (2021) Vol. 529, pp. 111254-111254
Closed Access | Times Cited: 78
Elena Cantero‐Navarro, Beatriz Fernández‐Fernández, Adrián M. Ramos, et al.
Molecular and Cellular Endocrinology (2021) Vol. 529, pp. 111254-111254
Closed Access | Times Cited: 78
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Alberto Ortíz, Charles J. Ferro, Olga Balafa, et al.
Nephrology Dialysis Transplantation (2021) Vol. 38, Iss. 1, pp. 10-25
Open Access | Times Cited: 49
Alberto Ortíz, Charles J. Ferro, Olga Balafa, et al.
Nephrology Dialysis Transplantation (2021) Vol. 38, Iss. 1, pp. 10-25
Open Access | Times Cited: 49
Antidiuretic Hormone and Serum Osmolarity Physiology and Related Outcomes: What Is Old, What Is New, and What Is Unknown?
Mehmet Kanbay, Sezen Yılmaz, Neris Di̇nçer, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 11, pp. 5406-5420
Open Access | Times Cited: 43
Mehmet Kanbay, Sezen Yılmaz, Neris Di̇nçer, et al.
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 11, pp. 5406-5420
Open Access | Times Cited: 43
COVID-19 and acute kidney injury
Lale A. Ertuğlu, Asiye Kanbay, Barış Afşar, et al.
Tuberkuloz ve Toraks (2020) Vol. 68, Iss. 4, pp. 407-418
Open Access | Times Cited: 41
Lale A. Ertuğlu, Asiye Kanbay, Barış Afşar, et al.
Tuberkuloz ve Toraks (2020) Vol. 68, Iss. 4, pp. 407-418
Open Access | Times Cited: 41
Epigenetics and Inflammation in Diabetic Nephropathy
Baoyi Shao, Shao‐Fei Zhang, Hai-Di Li, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 40
Baoyi Shao, Shao‐Fei Zhang, Hai-Di Li, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 40
Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
Collin Vandemark, Jimmy Nguyen, Zhi‐Qing Zhao
Molecules (2023) Vol. 28, Iss. 3, pp. 1369-1369
Open Access | Times Cited: 15
Collin Vandemark, Jimmy Nguyen, Zhi‐Qing Zhao
Molecules (2023) Vol. 28, Iss. 3, pp. 1369-1369
Open Access | Times Cited: 15
Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a mendelian randomization study
Xin Lv, Yan Shang, Yong Ning, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Xin Lv, Yan Shang, Yong Ning, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Shear Wave Elastography: A Review on the Confounding Factors and Their Potential Mitigation in Detecting Chronic Kidney Disease
William T. H. Lim, Ean Hin Ooi, Ji Jinn Foo, et al.
Ultrasound in Medicine & Biology (2021) Vol. 47, Iss. 8, pp. 2033-2047
Closed Access | Times Cited: 26
William T. H. Lim, Ean Hin Ooi, Ji Jinn Foo, et al.
Ultrasound in Medicine & Biology (2021) Vol. 47, Iss. 8, pp. 2033-2047
Closed Access | Times Cited: 26
From inflammation to renal fibrosis: A one-way road in autoimmunity?
Dario Roccatello, Hui Y. Lan, Savino Sciascia, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 4, pp. 103466-103466
Closed Access | Times Cited: 10
Dario Roccatello, Hui Y. Lan, Savino Sciascia, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 4, pp. 103466-103466
Closed Access | Times Cited: 10
The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications
Chen-Ting Hung, Yi‐Wei Tsai, Yu‐Shuo Wu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 15
Chen-Ting Hung, Yi‐Wei Tsai, Yu‐Shuo Wu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 15
Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
Javier Donate‐Correa, María Dolores Sánchez-Niño, Ainhoa González-Luis, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 12, pp. 2200-2213
Open Access | Times Cited: 12
Javier Donate‐Correa, María Dolores Sánchez-Niño, Ainhoa González-Luis, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 12, pp. 2200-2213
Open Access | Times Cited: 12
Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats
Feng Bai, Lihui Zhang, Weiwei Zhang, et al.
European Journal of Pharmacology (2019) Vol. 867, pp. 172844-172844
Closed Access | Times Cited: 16
Feng Bai, Lihui Zhang, Weiwei Zhang, et al.
European Journal of Pharmacology (2019) Vol. 867, pp. 172844-172844
Closed Access | Times Cited: 16
Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy
Jia Li, Dongwei Liu, Jingjing Ren, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Jia Li, Dongwei Liu, Jingjing Ren, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 4
New Landmarks to Slow the Progression of Chronic Kidney Disease
Marco Simonini, Giuseppe Vezzoli
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 2-2
Open Access | Times Cited: 7
Marco Simonini, Giuseppe Vezzoli
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 2-2
Open Access | Times Cited: 7
Chronic Kidney Disease: Current State of the Problem
М. М. Батюшин
Rational Pharmacotherapy in Cardiology (2020) Vol. 16, Iss. 6, pp. 938-947
Open Access | Times Cited: 10
М. М. Батюшин
Rational Pharmacotherapy in Cardiology (2020) Vol. 16, Iss. 6, pp. 938-947
Open Access | Times Cited: 10
Neprilysin, the kidney brush border neutral proteinase: a possible potential target for ischemic renal injury
Runali Sankhe, Manas Kinra, Jayesh Mudgal, et al.
Toxicology Mechanisms and Methods (2019) Vol. 30, Iss. 2, pp. 88-99
Closed Access | Times Cited: 9
Runali Sankhe, Manas Kinra, Jayesh Mudgal, et al.
Toxicology Mechanisms and Methods (2019) Vol. 30, Iss. 2, pp. 88-99
Closed Access | Times Cited: 9
Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD
Marina P. C. Maires, Krislley R Pereira, Everidiene K. V. B. Silva, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 5
Marina P. C. Maires, Krislley R Pereira, Everidiene K. V. B. Silva, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 5
Clinical efficacy and safety of astragalus injection combined with ACEI/ARB in the treatment of diabetic kidney disease: Protocol for a systematic review and meta-analysis
Zhiyue Zhu, Qi Zhang, Le Liu, et al.
Medicine (2022) Vol. 101, Iss. 49, pp. e31490-e31490
Open Access | Times Cited: 4
Zhiyue Zhu, Qi Zhang, Le Liu, et al.
Medicine (2022) Vol. 101, Iss. 49, pp. e31490-e31490
Open Access | Times Cited: 4
Metabolic reprogramming: Unveiling the therapeutic potential of targeted therapies against kidney disease
Shubhangi Saxena, Neha Dagar, Vishwadeep Shelke, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103765-103765
Closed Access | Times Cited: 2
Shubhangi Saxena, Neha Dagar, Vishwadeep Shelke, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 11, pp. 103765-103765
Closed Access | Times Cited: 2
Metagenomics and metabolomics to investigate the effect of Amygdalus mongolica oil on intestinal microbiota and serum metabolites in rats
Run-Xi Wang, Hong-Bing Zhou, Jin Gao, et al.
Phytomedicine (2024) Vol. 136, pp. 156335-156335
Closed Access
Run-Xi Wang, Hong-Bing Zhou, Jin Gao, et al.
Phytomedicine (2024) Vol. 136, pp. 156335-156335
Closed Access
Synergic Renoprotective Effects Of Combined ASC Therapy With RAAS Blockade In Experimental Advanced CKD
Marina P. C. Maires, Krislley R Pereira, Everidiene KVB Silva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Marina P. C. Maires, Krislley R Pereira, Everidiene KVB Silva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Management of patients with chronic kidney disease: a French medical centre database analysis
Matthieu Ariza, Steven W. Martin, Mikaël Dusenne, et al.
Family Practice (2023) Vol. 41, Iss. 3, pp. 262-269
Closed Access
Matthieu Ariza, Steven W. Martin, Mikaël Dusenne, et al.
Family Practice (2023) Vol. 41, Iss. 3, pp. 262-269
Closed Access
Molecular Mechanisms of Apoptosis of Glomerular Podocytes in Diabetic Nephropathy
А. О. Шпаков, Еlena Kaznacheyeva
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2020) Vol. 14, Iss. 3, pp. 205-222
Closed Access
А. О. Шпаков, Еlena Kaznacheyeva
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2020) Vol. 14, Iss. 3, pp. 205-222
Closed Access
